Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJul 29, 2015Zonisamide CapsulesCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1273-2015Class IITerminatedJul 29, 2015Metoprolol Succinate Extended-Release TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1272-2015Class IITerminatedJul 29, 2015Metoprolol Succinate Extended-Release TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1271-2015Class IITerminatedJul 29, 2015Metoprolol Succinate Extended-Release TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1270-2015Class IITerminatedJul 29, 2015Lansoprazole Delayed-Release CapsulesCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1269-2015Class IITerminatedJul 29, 2015Lansoprazole Delayed-Release CapsulesCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1268-2015Class IITerminatedJul 29, 2015Famotodine TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1267-2015Class IITerminatedJul 29, 2015Famotodine TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1266-2015Class IITerminatedJul 29, 2015Famotodine TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1265-2015Class IITerminatedJul 29, 2015Azithromycin TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1264-2015Class IITerminatedJul 29, 2015Azithromycin TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1263-2015Class IITerminatedJul 29, 2015Zolpidem Tartrate TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1262-2015Class IITerminatedJul 29, 2015Lisinopril Tablets USPCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1261-2015Class IITerminatedJul 29, 2015Lisinopril Tablets USPCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1260-2015Class IITerminatedJul 29, 2015Lisinopril Tablets USPCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1259-2015Class IITerminatedJul 29, 2015Lisinopril Tablets USPCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1258-2015Class IITerminatedJul 29, 2015Lisinopril Tablets USPCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1257-2015Class IITerminatedJul 29, 2015Amlodipine Besylate TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1256-2015Class IITerminatedJul 29, 2015Amlodipine Besylate TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1255-2015Class IITerminatedJul 29, 2015Zonisamide CapsulesCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1254-2015Class IITerminatedJul 29, 2015Tamsulosin Hydrochloride CapsulesCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1253-2015Class IITerminatedJul 29, 2015Metoprolol Succinate Extended-Release TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1252-2015Class IITerminatedJul 29, 2015Lansoprazole Delayed-Release CapsulesCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1251-2015Class IITerminatedJul 29, 2015Famotodine TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1250-2015Class IITerminatedJul 29, 2015Clarithromycin TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1249-2015Class IITerminatedJul 29, 2015Azithromycin TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1248-2015Class IITerminatedJul 29, 2015Zolpidem Tartrate TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1247-2015Class IITerminatedJul 29, 2015Extended Phenytoin Sodium CapsulesCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1246-2015Class IITerminatedJul 29, 2015Lamotrigine Extended-Release TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1245-2015Class IITerminatedJul 29, 2015Lisinopril Tablets USPCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1244-2015Class IITerminatedJul 29, 2015Amlodipine Besylate TabletsCGMP Deviations: Firm did not adequately investigate customer complaints.Wockhardt Usa Inc. · D-1243-2015Class IIOngoingJul 22, 2015KETOROLAC Tromethamine InjCrystallization; identified as calcium salt of KetorolacHospira Inc. · D-1242-2015Class IIOngoingJul 22, 2015KETOROLAC Tromethamine InjCrystallization; identified as calcium salt of KetorolacHospira Inc. · D-1241-2015Class IITerminatedJul 22, 20150.9% Sodium Chloride Injection USPLack of assurance of sterility: Potential channel leaks near the threaded vial port.Hospira Inc. · D-1240-2015Class IIITerminatedJul 22, 2015HydrOXYzine Hydrochloride TabletsFailed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadableQualitest Pharmaceuticals · D-1239-2015Class IIITerminatedJul 22, 2015Carb-O-Philic 40 CreamCGMP Deviation: Poor container closure of the bulk storage containerGeritrex Corp · D-1238-2015Class IITerminatedJul 22, 2015Nitroglycerin Transdermal System 0.4 mg/hrFailed Impurities/Degradation Specifications: Two lots failed specification for unknown impurity at the 24 month stability testing.Kremers Urban Pharmaceuticals, Inc. · D-1237-2015Class IITerminatedJul 22, 2015Nitroglycerin Transdermal System 0.2 mg/hrFailed Impurities/Degradation Specifications: failed specification for unknown impurity at the 24 month stability testing.Kremers Urban Pharmaceuticals, Inc. · D-1236-2015Class IIITerminatedJul 22, 2015Desmopressin Acetate TabletsTablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.American Health Packaging · D-1235-2015Class IITerminatedJul 22, 2015Rifampin for InjectionFailed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradationFresenius Kabi USA, LLC · D-1234-2015